Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.
Watson-Jones D, Changalucha J, Maxwell C, Whitworth H, Mutani P, Kemp TJ, Kamala B, Indangasi J, Constantine G, Hashim R, Mwanzalima D, Wiggins R, Mmbando D, Connor N, Pavon MA, Lowe B, Kapiga S, Mayaud P, de Sanjosé S, Dillner J, Hayes RJ, Lacey CJ, Pinto L, Baisley K.
Lancet Glob Health. 2025 Feb;13(2):e319-e328.
DOI: 10.1016/S2214-109X(24)00477-7.
PMID: 39890232;
PMCID: PMC11783036.